Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


07.08.2017

1 Acta Psychiatr Scand
1 Am J Psychiatry
1 Can J Psychiatry
2 J Clin Psychopharmacol
2 Mol Psychiatry
7 Psychiatry Res
9 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. SPERANDEO R, Maldonato MN, Dell'Orco S
    Comment on 'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia'.
    Acta Psychiatr Scand. 2017 Aug 4. doi: 10.1111/acps.12782.
    PubMed     Text format    


    Am J Psychiatry

  2. SANDOVAL LR, Torous J, Keshavan MS
    Smartphones for Smarter Care? Self-Management in Schizophrenia.
    Am J Psychiatry. 2017;174:725-728.
    PubMed     Text format    


    Can J Psychiatry

  3. ABIDI S, Mian I, Garcia-Ortega I, Lecomte T, et al
    CPA Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.
    Can J Psychiatry. 2017 Jan 1:706743717720197. doi: 10.1177/0706743717720197.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  4. ZHENG W, Wang S, Ungvari GS, Ng CH, et al
    Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2017;37:341-346.
    PubMed     Text format     Abstract available

  5. LOPEZ LV, Shaikh A, Merson J, Greenberg J, et al
    Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
    J Clin Psychopharmacol. 2017;37:310-314.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  6. NIMGAONKAR VL, Prasad KM, Chowdari KV, Severance EG, et al
    The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available

  7. GUR RE, Bassett AS, McDonald-McGinn DM, Bearden CE, et al
    A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    Psychiatry Res

  8. OKUBO R, Inoue T, Hashimoto N, Suzukawa A, et al
    The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia.
    Psychiatry Res. 2017;257:126-131.
    PubMed     Text format     Abstract available

  9. SU YA, Yan F, Li Q, Xiang YT, et al
    Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012).
    Psychiatry Res. 2017;257:132-136.
    PubMed     Text format     Abstract available

  10. CALDANI S, Amado I, Bendjemaa N, Vialatte F, et al
    Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia.
    Psychiatry Res. 2017;256:490-497.
    PubMed     Text format     Abstract available

  11. VERAS AB, Cougo S, Meira F, Peixoto C, et al
    Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective.
    Psychiatry Res. 2017;257:172-178.
    PubMed     Text format     Abstract available

  12. TULLY S, Wells A, Morrison AP
    Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study.
    Psychiatry Res. 2017;257:186-192.
    PubMed     Text format     Abstract available

  13. DEMRO C, Rowland L, Wijtenburg SA, Waltz J, et al
    Glutamatergic metabolites among adolescents at risk for psychosis.
    Psychiatry Res. 2017;257:179-185.
    PubMed     Text format     Abstract available

  14. SMIRNOVA D, Clark M, Jablensky A, Badcock JC, et al
    Action (verb) fluency deficits in schizophrenia spectrum disorders: linking language, cognition and interpersonal functioning.
    Psychiatry Res. 2017;257:203-211.
    PubMed     Text format     Abstract available


    Schizophr Res

  15. AJNAKINA O, Lally J, Di Forti M, Stilo SA, et al
    Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30453.
    PubMed     Text format     Abstract available

  16. ADAMS SA, Nasrallah HA
    Multiple retinal anomalies in schizophrenia.
    Schizophr Res. 2017 Jul 26. pii: S0920-9964(17)30419.
    PubMed     Text format     Abstract available

  17. LALLY J, Ajnakina O, Stubbs B, Williams HR, et al
    Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.
    Schizophr Res. 2017 Jul 27. pii: S0920-9964(17)30448.
    PubMed     Text format     Abstract available

  18. BRAEUTIGAM S, Dima D, Frangou S, James A, et al
    Dissociable auditory mismatch response and connectivity patterns in adolescents with schizophrenia and adolescents with bipolar disorder with psychosis: A magnetoencephalography study.
    Schizophr Res. 2017 Jul 28. pii: S0920-9964(17)30459.
    PubMed     Text format     Abstract available

  19. FEATHERSTONE RE, Melnychenko O, Siegel SJ
    Mismatch negativity in preclinical models of schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30450.
    PubMed     Text format     Abstract available

  20. RATHEESH A, Cotton SM, Davey CG, Lin A, et al
    Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.
    Schizophr Res. 2017 May 4. pii: S0920-9964(17)30223.
    PubMed     Text format     Abstract available

  21. EACK SM
    Promoting long-term functional improvement after cognitive remediation in schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30454.
    PubMed     Text format    

  22. HOOPER SR, Shashi V
    Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30451.
    PubMed     Text format    

  23. GILLESPIE SM, Abu-Akel AM
    Evidence for benefits in comorbid psychopathy and schizophrenia.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30457.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: